Delivery Order SPE2DR25D1017-SPE2DR26F8YSH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,245.08 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 15 mg/0.5 mL pen injectors on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order with no set-aside designation. The product will be delivered to the agency's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $2,173.01 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens. The contract, which is a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA, requires delivery by October 22, 2025, to the company's distribution facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a $1,143.89 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is scheduled for completion by August 18, 2025. This delivery order was competitively awarded without...
- The Defense Logistics Agency awarded a $4,839.72 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract is expected to be completed by September 15, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,848.75 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injectors. This competitive, firm fixed-price delivery order is scheduled for completion by August 21, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single transaction under the company's larger pharmaceutical supply framework with the federal...
- The Defense Logistics Agency awarded a $14,942.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pen injectors on July 11, 2025, with completion scheduled for July 14, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,719.35 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pen injectors on September 26, 2025, with completion targeted for September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $37,571.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 ml pen injections. This delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a small-value pharmaceutical procurement under a larger indefinite delivery contract framework. The contract was competitively awarded with no set-aside designation, and performance will be executed from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors with a firm fixed price ceiling value of $1,808.47. The delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $21,483.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pen injectors on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F8YSHDelivery Order
The Defense Logistics Agency awarded a $8,901.35 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pen injectors on October 29, 2025, with an ultimate completion date of October 30, 2025. The award was made without a set-aside designation through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the primary vendor for this delivery order, which is classified as a child contract under a larger vehicle. The pharmaceutical will be delivered to the Conshohocken, PA location. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. The Zepbound delivery represents a small-value transaction consistent with the company's extensive portfolio of federal medical product deliveries, which spans multiple therapeutic domains including specialty medications, vaccines, and medical devices across the defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 10/29/25 |